Evidence map›Paper›PMID 40196803›Full record

ArticleOman medical journal2024

Safety of COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases: A Cross-sectional Study in Egypt.

Nevin Hammam, Doaa Mosad, Amira M Ibrahim, Yousra H Abdel-Fattah, Hany M Aly, Hanan M El-Saadany, Maha Nassr, Abdelhafeez Moshrif, Hanan M Fathi, Samah I Nasef and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oman medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Nevin HammamDepartment of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University, Assiut, Egypt.
Doaa MosadRheumatology Department, Faculty of Medicine, Mansoura University, Dakahlia, Egypt.
Amira M IbrahimRheumatology Department, Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
Yousra H Abdel-FattahRheumatology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Hany M AlyRheumatology Department, Faculty of Medicine, Al-Azhar University (Boys), Cairo, Egypt.
Hanan M El-SaadanyRheumatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Maha NassrRheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Abdelhafeez MoshrifRheumatology Department, Faculty of Medicine, Al-Azhar University, Assuit, Egypt.
Hanan M FathiRheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Samah I NasefRheumatology and Rehabilitation Department, Faculty of Medicine, Suez-Canal University, Ismailia, Egypt.
Faten IsmailRheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Rawhya R El ShereefRheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Osman HammamDepartment of Rheumatology, Faculty of Medicine, New Valley University, New Valley, Egypt.
Mervat I Abd-ElazeemRheumatology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Enas A AbdelaleemRheumatology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Abdelrahman Mohamed ElsayedFaculty of Medicine, Mansoura University, Mansoura, Egypt.
Samar TharwatInternal Medicine Department, Rheumatology Unit, Mansoura University, Dakahlia, Egypt.
Tamer A GheitaRheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the incidence and associated risk factors of adverse events following COVID-19 vaccination in patients with inflammatory and non-inflammatory rheumatic and musculoskeletal diseases (I-RMD and NI-RMD, respectively). Methods: The Egyptian College of Rheumatology COVID-19 Study Group investigated physician-reported data (ECR-VaXurvey3) of RMD patients vaccinated against COVID-19 from December 2021 to June 2022, including their demographics, vaccination type, RMD diagnosis, treatments, post-vaccine flares, and other adverse events. The control group consisted of healthy, vaccinated individuals. Results: The ECR-VaXurvey3 included 890 vaccinated RMD patients, predominantly women (73.3%) with a mean age of 44.4 ± 12.1 years, and 172 controls. The RMD group comprised 816 (91.7%) with I-RMD and 74 (8.3%) with NI-RMD. The frequency of adverse events was comparable between the RMD and control groups. In RMD patients, injection site pain (59.9%) was the most reported adverse event. Post-vaccination COVID-19 infections and disease flares were reported in 2.9% and 12.1% of I-RMD patients and in 8.1% and 9.5% of NI-RMD patients ( Conclusions: Adverse events following COVID-19 vaccinations in patients with RMD are comparable to controls.

Indexed as

Adverse EffectCOVID-19 VaccineEgyptRheumatic and Musculoskeletal DiseaseRisk FactorsSafety

Identifiers

PMID40196803
PMCPMC11973885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.